Mental Health and Substance Use Treatment in Cherry Hill, NJ
Now In Network with BCBS of NJ
856-600-0951
Cherry Hill
856-600-0951

Treat Depression With SPRAVATO in Philadelphia

It's hard to live a satisfying life when depression is getting in the way. And while there are a range of treatment options available, they don’t all work in every situation. If you feel like you’ve been through them all but still experience overwhelming depression, The Counseling Center at Cherry Hill might have a solution. Our licensed clinicians have experience treating treatment-resistant depression with a prescription medicine called SPRAVATO® in Philadelphia.

What Is SPRAVATO?

Spravato (esketamine) CIII is taken as a nasal spray and utilized to treat treatment-resistant depression (TRD). If you have sought help from a minimum of two antidepressant medicines with little alleviation of depressive symptoms, utilizing SPRAVATO may be beneficial. Numerous people finally gain a reprieve from their depression when using SPRAVATO alongside an antidepressant. Many people who take SPRAVATO in tandem with an oral antidepressant report lowered depressive symptoms by four weeks. Clinical studies have indicated that the advantages of taking SPRAVATO can be felt within 24 hours of the opening dose.

SPRAVATO is a derivative of ketamine. It is the only formulation of ketamine in Philadelphia and the US that is authorized for the treatment of depression. It triggers certain brain neurotransmitters and helps them transmit messages more effectively to regulate mood and decrease harmful symptoms of depression.

What Are The Signs Of Treatment-Resistant Depression?

Numerous people are able to manage symptoms of depression with commonly used medications. But if you’ve taken no less than two different antidepressants with minimal or zero improvement, you may have treatment-resistant depression. Signs of this condition include:

  • Little to no improvement with antidepressants and therapy following a few weeks
  • Brief improvements offset by a return of symptoms
  • Longer and more severe incidents of depression
  • Newly experienced or heightened levels of anxiety

If you are afflicted with any of the above, seek advice from a medical professional to explore your options.

Who May Benefit From SPRAVATO?

SPRAVATO is prescribed only to adults diagnosed with treatment-resistant depression. It comes with side effects, and some pre-existing conditions might preclude you from taking SPRAVATO.

At The Counseling Center at Cherry Hill, we only administer suitable forms of treatment based on your unique circumstances. Prior to prescribing medication to manage mental disorders, we will review your medical history. You’ll work with one of our medical professionals to decide if SPRAVATO is appropriate for you along with other antidepressants and continual therapy.

*Insurance and Self-Pay options are available.

If we determine you are a viable candidate for SPRAVATO at our Philadelphia site, we’ll proceed with the nasal spray and give you a schedule for receiving it at our approved facility. You may utilize SPRAVATO for as long as you and your clinician feel it helps you deal with your depression.
 

How Will SPRAVATO Play A Role In Substance Use Recovery?

Numerous people who battle treatment-resistant depression develop substance use disorders. Depression makes it difficult to do all the steps required to overcome these conditions. At The Counseling Center at Cherry Hill, we provide care for substance use disorders and the mental illnesses at their core. If you haven’t found a worthwhile treatment for depression at present, and it’s hindering your addiction recovery, we might prescribe SPRAVATO.

When you feel better, it’s easier to abstain from alcohol and drugs. SPRAVATO can help you feel the energy and motivation you require to keep going with your addiction therapy and keep yourself sober.

Medicare Patients Can Now Get SPRAVATO® in Philadelphia, New Jersey

We are delighted to announce that we now accept Medicare for SPRAVATO® treatment in Philadelphia, New Jersey. This new medication is designed to support those who face treatment-resistant depression. Our team is dedicated to providing holistic care and assistance to guarantee that you can access this game-changing treatment. With Medicare now accepted for SPRAVATO®, even more people can reap the rewards of this cutting-edge approach to combating depression in Philadelphia.  

Battling With Substance Use And Depression? We Are Here To Help

If depression is impeding your substance use recovery, help is available. Dial 856-600-0951 or complete the form on this page, and we’ll respond immediately, despite the hour or day. We are here for you today. You don’t have to experience this on your own.